Rosen MB, Das KP, Rooney J, et al
Successful CagriSema dosing requires following proven titration schedules - both peptides escalating over 13-17 weeks to 2.4mg weekly each - with proactive side effect management during the critical weeks 9-16 when nausea peaks
Reader outcomes Which programs our readers actually choose, start, and stay with
However, microdosing hasnt been studied in clinical trials, so theres no reliable data to suggest how well it works
GIP receptor activation enhances insulin secretion, modulates adipose tissue metabolism, and appears to synergise with GLP-1 activity to produce greater metabolic effects than either hormone alone as demonstrated by the clinical performance of the dual agonist tirzepatide
Find a Lab Near You Transparent Pricing Here's exactly what you pay